SNOA
Sonoma Pharmaceuticals
$1.15
+$0.01 (+0.88%)Jul 27, 2026
Key metrics
The numbers that frame SNOA today
- Market cap
- $5.50M
- P/E (TTM)
- -1.7
- EV / FCF
- -1.0
- Gross margin
- 38%
- EV / Sales
- 0.2
- ROIC
- -47.3%
- Div yield
- 0%
- Debt / equity
- 0.3
- 52wk Low
- $0.85
- 52wk High
- $6.92
Growth
Revenue and earnings trend for SNOA
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about SNOA
Is Sonoma Pharmaceuticals a good buy?
No. Sonoma Pharmaceuticals has weak quality and poor momentum. Both signals point to a weaker setup. Growth looks excellent, which supports the long-term business case, but that is not enough to offset the weak setup. We think Sonoma Pharmaceuticals is selling at a very high price.
What is the market capitalization of SNOA?
Sonoma Pharmaceuticals's market capitalization is $5.50M.
What is the P/E ratio for SNOA stock?
Sonoma Pharmaceuticals's current P/E ratio is -1.7.
What is the 52-week high for SNOA stock?
The 52-week high for Sonoma Pharmaceuticals is $6.92. The current close of $1.15 is 83.4% below that high.
What is the 52-week low for SNOA stock?
The 52-week low for Sonoma Pharmaceuticals is $0.85. The current close of $1.15 is 35.3% above that low.
Does SNOA stock pay dividends?
Sonoma Pharmaceuticals does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for SNOA?
Sonoma Pharmaceuticals's Debt / Equity ratio is 0.27.